F. Morschhauser, J. Radford, and A. Van-hoof, Phase III Trial of Consolidation Therapy With Yttrium-90???Ibritumomab Tiuxetan Compared With No Additional Therapy After First Remission in Advanced Follicular Lymphoma, Journal of Clinical Oncology, vol.26, issue.32, pp.5156-64, 2008.
DOI : 10.1200/JCO.2008.17.2015

J. Strosberg, G. El-haddad, and E. Wolin, Lu-Dotatate for Midgut Neuroendocrine Tumors, New England Journal of Medicine, vol.376, issue.2, pp.125-160, 2017.
DOI : 10.1056/NEJMoa1607427

C. Parker, S. Nilsson, and D. Heinrich, Alpha Emitter Radium-223 and Survival in Metastatic Prostate Cancer, New England Journal of Medicine, vol.369, issue.3, pp.213-236, 2013.
DOI : 10.1056/NEJMoa1213755

P. Hoskin, O. Sartor, O. Sullivan, and J. , Efficacy and safety of radium-223 dichloride in patients with castration-resistant prostate cancer and symptomatic bone metastases, with or without previous docetaxel use: a prespecified subgroup analysis from the randomised, double-blind, phase 3 ALSYMPCA trial, The Lancet Oncology, vol.15, issue.12, pp.1397-406, 2014.
DOI : 10.1016/S1470-2045(14)70474-7

M. Makvandi, E. Dupis, and J. Engle, Alpha-Emitters and Targeted Alpha Therapy in Oncology: from Basic Science to Clinical Investigations, Targeted Oncology, vol.46, issue.2, 2018.
DOI : 10.1053/j.semnuclmed.2015.10.012

M. Autenrieth, C. Seidl, and F. Bruchertseifer, Treatment of carcinoma in situ of the urinary bladder with an alpha-emitter immunoconjugate targeting the epidermal growth factor receptor: a pilot study, European Journal of Nuclear Medicine and Molecular Imaging, vol.10, 2018.
DOI : 10.1371/journal.pone.0130249

J. Jurcic, F. Ravandi, and J. Pagel, Phase I trial of ?-particle therapy with actinium-225 (225Ac)-lintuzumab (anti-CD33) and low-dose cytarabine (LDAC) in older patients with untreated acute myeloid leukemia (AML), J Clin Oncol, vol.33, issue.7050, 2015.
DOI : 10.1200/jco.2011.29.15_suppl.6516

C. Kratochwil, F. Bruchertseifer, and F. Giesel, 225Ac-PSMA-617 for PSMA-Targeted ??-Radiation Therapy of Metastatic Castration-Resistant Prostate Cancer, Journal of Nuclear Medicine, vol.57, issue.12, pp.1941-1945, 2016.
DOI : 10.2967/jnumed.116.178673

URL : http://jnm.snmjournals.org/content/57/12/1941.full.pdf